FDA Webview
X
latest-news

Two Hyman, Phelps & McNamara attorneys describe the impacts on industry if FDA responds to a congressional push for more pre-review of direct-to-consumer ads.

latest-news

HHS secretary Robert F. Kennedy Jr. curtails his public commentary on vaccines as part of a deliberate political strategy by the Trump administration for its midterm election campaign.

LATEST NEWS

View All
motusgi
Will the Push for DTC Pre-Review Grow?

Two Hyman, Phelps & McNamara attorneys describe the impacts on industry if FDA responds to a congressional push for more pre-review of direct-to-consumer ads.

motusgi
RFK Jr. Tones Down Vaccine Skepticism in Run Up to Midterms

HHS secretary Robert F. Kennedy Jr. curtails his public commentary on vaccines as part of a deliberate political strategy by the Trump administration for its midterm election campaign.

motusgi
Alymsys Patient Brochure False or Misleading: FDA

The CDER Office of Prescription Drug Promotion says an Amneal patient brochure for its Avastin biosimilar Alymsys is false or misleading in several ways.

motusgi
FDA Budget Proposal Signals Push for Tighter Ad Oversight

Law firm Sheppard breaks down some of FDA’s proposals in its budget documents that industry should keep a close eye on, including new DTC ad authorities that signal enforcement will likely intensify under this administration.

newsletter-first

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Animal Drugs

View All
medical-devices
Read More
Enforcement, Advertising Oversight Shape Regulatory Landscape: Legal Update

A legal update from ArentFox highlight several emerging regulatory and enforcement developments at FDA thatare expected to have significant implicatio...

medical-devices
Read More
Partial Hold on Myotonic Dystrophy Type 1 Therapy

FDA places a partial clinical hold on a mid-stage U.S. trial of PepGen Inc.’s experimental therapy for myotonic dystrophy Type 1.

medical-devices
Read More
FDA Warns Elanco Animal Health About Pradalex Ads

The Center for Veterinary Medicine warns Elanco Animal Health about false and misleading claims in promotional materials for its Pradalex that treats ...

medical-devices
Read More
Antimicrobial Drug Duration of Use Guidance

FDA publishes a guidance with recommendations for how sponsors of animal drugs may facilitate changes to the approved conditions of use of specific ty...

Biologics

View All
medical-devices
Read More
Organogenesis Advances ReNu Toward FDA Filing After Key Meeting

Organogenesis says it has reached agreement with FDA that clears the way for a rolling BLA submission for its knee osteoarthritis product ReNu.

medical-devices
Read More
Positive Phase 3 Date for Subcutaneous Tepezza: Amgen

Amgen reports positive topline results from a Phase 3 trial evaluating a subcutaneous version of its thyroid eye disease drug Tepezza (teprotumumab-tr...

medical-devices
Read More
FDA Flags Quality System Gaps at CSL Behring Site

FDA posts a Form 483 that identifies deficiencies in quality system procedures at a manufacturing facility operated by CSL Behring GmbH in Marburg, Ge...

medical-devices
Read More
CBER File Over Protest SOPP

CBER publishes a Standard Operating Policy and Procedure on filing an application over protest after a Center refusal-to-file decision.

FDA General

View All
medical-devices
Read More
RFK Jr. Tones Down Vaccine Skepticism in Run Up to Midterms

HHS secretary Robert F. Kennedy Jr. curtails his public commentary on vaccines as part of a deliberate political strategy by the Trump administration ...

medical-devices
Read More
FDA Budget Proposal Signals Push for Tighter Ad Oversight

Law firm Sheppard breaks down some of FDA’s proposals in its budget documents that industry should keep a close eye on, including new DTC ad authoriti...

medical-devices
Read More
Doctor Failed to Follow Investigational Plan: FDA

FDA warns Newport Beach, CA-based physician Ehsan Sadri about failing to follow the investigational plan in two clinical trials.

medical-devices
Read More
FDA Budget Request Seeks 3% Increase

FDA’s just-released proposed fiscal year 2027 budget seeks a 3.3% increase or about $200 million to fund the agency’s operations.

newsletter-second

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Federal Register

View All
motusgi
Read More
Mitapivat Moving Toward Accelerated Approval in Sickle Cell: Agios

Agios Pharmaceuticals says it plans to seek accelerated approval for mitapivat in sickle cell diseas...

motusgi
Read More
PDUFA Public Meeting for User Fee Reauthorization

Federal Register notice: FDA announces a 7/14 public meeting to discuss proposed recommendations for...

motusgi
Read More
Generic Drug Fee Program Reauthorization Meeting

Federal Register notice: FDA hosts a 7/11 public meeting on the reauthorization of the Generic Drug ...

motusgi
Read More
FDA Withdraws and Reissues 2 Guidances

FDA says it is withdrawing two recent final guidances on cell- and tissue-based products and reissui...

Human Drugs

View All
motusgi
Read More
Workshop on Novel Surrogate Endpoints for Rare Disease Drugs

FDA announces a 5/18 virtual public workshop aimed at advancing the use of novel surrogate endpoints...

motusgi
Read More
Insmed Halts Brensocatib Program After Mid-Stage Trial Miss

Insmed discontinues development of its drug candidate brensocatib for hidradenitis suppurativa after...

motusgi
Read More
See Supply Chain Strategy as Core Regulatory Function: Attorney

Baker Hostetler attorney Winston Kirton says life sciences companies that are active in both the U.S...

motusgi
Read More
FDA Not Keeping Pace with Non-Oncology Basket Trials: Column

A Clinical Trial Vanguard online column explains how a 2022 FDA master protocol guidance has not kep...

Marketing

View All
motusgi
Read More
Will the Push for DTC Pre-Review Grow?

Two Hyman, Phelps & McNamara attorneys describe the impacts on industry if FDA responds to a congres...

motusgi
Read More
Alymsys Patient Brochure False or Misleading: FDA

The CDER Office of Prescription Drug Promotion says an Amneal patient brochure for its Avastin biosi...

motusgi
Read More
Modernize DTC Ads with QR Code: WLF

A Washington Legal Foundation background document suggests that Congress change direct-to-consumer d...

motusgi
Read More
Influencers’ Drug Promotions Pose Public Health Risks: JAMA

A new study published in JAMA Network Open highlights growing public health concerns over prescripti...

Medical Devices

View All
motusgi
Read More
Medline Industries QS Violations Cited

FDA warns Glens Falls, NY-based Medline Industries about Quality System violations in its manufactur...

motusgi
Read More
FDA Opens READI-Home Innovation Challenge

FDA solicits applications for its new READI-Home innovation challenge to use medical technology in t...

motusgi
Read More
FDA Patient Preference Guide Addresses 510(k) Applicability

FDA’s updated guidance on how patient preference information can be incorporated into regulatory dec...

motusgi
Read More
Anumana Pulmonary Hypertension AI Tool Wins Clearance

FDA clears an Anumana 510(k) for an artificial intelligence–based tool designed to detect early sign...